Viewing data from:

THIOTHIXENE

ANDA

THIOTHIXENE | A211642 | NOVITIUM PHARMA LLC

4 strengths0 unique patents0 unique exclusivities

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-07-15 | 4 NDCs

Highest NADAC/Unit

$2.01

per ea

Lowest NADAC/Unit

$0.6532

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
70954001710THIOTHIXENE 10 MG CAPSULE	$2.01	EA	Generic	—	2026-06-17
70954001610THIOTHIXENE 5 MG CAPSULE	$1.37	EA	Generic	—	2026-06-17
70954001510THIOTHIXENE 2 MG CAPSULE	$0.8254	EA	Generic	—	2026-06-17
70954001410THIOTHIXENE 1 MG CAPSULE	$0.6532	EA	Generic	—	2026-04-22

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

VA Federal Supply Schedule

Government-negotiated contract prices | 4 NDCs (4 FSS)

Lowest Price

$94.92

Highest Price

$270.12

FSS NDCs

Big4 NDCs

Description	Price	Type	Vendor	Contract End
51407-0275-01THIOTHIXENE HCL 1MG CAP	$94.92	FSS	Golden State Medical Supply, Inc.	06/14/2028
51407-0276-01THIOTHIXENE HCL 2MG CAP	$125.85	FSS	Golden State Medical Supply, Inc.	06/14/2028
51407-0277-01THIOTHIXENE HCL 5MG CAP	$191.38	FSS	Golden State Medical Supply, Inc.	06/14/2028
51407-0278-01THIOTHIXENE HCL 10MG CAP	$270.12	FSS	Golden State Medical Supply, Inc.	06/14/2028

Source: VA Federal Supply Schedule (va.gov). Prices are government-negotiated contract prices.

API Supply Chain3 active DMFs2 inactive

3 active API suppliers hold Drug Master Files for this ingredient.

ORGAPHARM SASTHIOTHIXENE

DMF 55661984

FINE CHEMICALS CORP PTY LTDTHIOTHIXENE

DMF 63091986

NOVITIUM PHARMA LLCTHIOTHIXENE USP

DMF 318392017

ORCHIMIE SA (PRODUITS CHIMIQUES ET BIOCHIMIQUES)InactiveTHIOTHIXENE DIHYDROCHLORIDE ANHYDROUS

DMF 59391985

INDUSTRIE CHIMICHE FARMACEUTICHE ITALIANE SPAInactiveTHIOTHIXENE BASE AND HC1

DMF 67761987

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Approval Letters

1 letter from Drugs@FDA

Date	Submission	Document
May 22, 2019	ORIG -1	View Letter (PDF)

Source: Drugs@FDA application documents.

Products (4)

Sort:

#001 — 1MG

0 patents0 exclusivities▴

CAPSULE;ORAL | Approved: Apr 5, 2019

No patent or exclusivity listings for this strength.

#002 — 2MG

0 patents0 exclusivities▾

CAPSULE;ORAL | Approved: Apr 5, 2019

#003 — 5MG

0 patents0 exclusivities▾

CAPSULE;ORAL | Approved: Apr 5, 2019

#004 — 10MG

0 patents0 exclusivities▾

CAPSULE;ORAL | Approved: Apr 5, 2019